Sionna Therapeutics (SION) Long-Term Investments (2024 - 2026)

Sionna Therapeutics has disclosed Long-Term Investments across 3 years of filings, most recently posting $73.8 million for Q1 2026.

• Long-Term Investments for Q1 2026 came in at $73.8 million, down 13.2% year-over-year; the trailing twelve-month figure through Mar 2026 was $73.8 million (down 13.2% YoY), and the FY2025 annual result was $74.4 million, up 262.94% from the prior year.
• Long-Term Investments came in at $73.8 million for Q1 2026 at Sionna Therapeutics, down from $74.4 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $85.0 million in Q1 2025 to a low of $20.5 million in Q4 2024.
• The 3-year median for Long-Term Investments is $74.6 million (2025), against an average of $67.5 million.
• Across the five-year window, Long-Term Investments soared 262.94% in 2025 and decreased 13.2% in 2026, its largest moves.
• Sionna Therapeutics' Long-Term Investments stood at $20.5 million in 2024, then jumped by 262.94% to $74.4 million in 2025, then fell by 0.86% to $73.8 million in 2026.
• The last three Long-Term Investments figures came in at $73.8 million (Q1 2026), $74.4 million (Q4 2025), and $76.7 million (Q3 2025), per Business Quant data.